2019 Q1 Form 10-K Financial Statement
#000156459019007350 Filed on March 12, 2019
Income Statement
Concept | 2019 Q1 | 2018 | 2017 Q4 |
---|---|---|---|
Revenue | $830.1K | $2.444M | $550.0K |
YoY Change | 165.05% | 56.79% | 22.22% |
Cost Of Revenue | $176.2K | $728.3K | $200.0K |
YoY Change | 63.02% | 44.13% | 100.0% |
Gross Profit | $653.9K | $1.716M | $340.0K |
YoY Change | 218.81% | 62.86% | -2.86% |
Gross Profit Margin | 78.77% | 70.2% | 61.82% |
Selling, General & Admin | $2.801M | $10.41M | $1.800M |
YoY Change | 25.31% | 77.87% | 73.08% |
% of Gross Profit | 428.43% | 606.45% | 529.41% |
Research & Development | $535.3K | $1.839M | $360.0K |
YoY Change | 43.75% | 4.96% | -12.2% |
% of Gross Profit | 81.86% | 107.16% | 105.88% |
Depreciation & Amortization | $21.63K | $69.68K | $0.00 |
YoY Change | 48.14% | 510.44% | |
% of Gross Profit | 3.31% | 4.06% | 0.0% |
Operating Expenses | $3.337M | $12.24M | $2.160M |
YoY Change | 27.94% | 61.07% | 48.97% |
Operating Profit | -$2.683M | -$10.53M | -$1.820M |
YoY Change | 11.65% | 60.79% | 65.45% |
Interest Expense | $42.77K | -$175.4K | $50.00K |
YoY Change | 1.37% | -51.13% | -145.45% |
% of Operating Profit | |||
Other Income/Expense, Net | $84.74K | $211.7K | |
YoY Change | 47.38% | -103.81% | |
Pretax Income | -$2.598M | -$10.32M | -$1.900M |
YoY Change | 10.56% | -14.72% | 57.02% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$2.598M | -$10.32M | -$1.900M |
YoY Change | 10.77% | -14.72% | 57.02% |
Net Earnings / Revenue | -312.99% | -422.11% | -345.45% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$5.216M | -$25.18M | -$246.8K |
COMMON SHARES | |||
Basic Shares Outstanding | 17.08M | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2019 Q1 | 2018 | 2017 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $9.234M | $6.541M | $12.96M |
YoY Change | -34.61% | -49.53% | |
Cash & Equivalents | $9.309M | $6.541M | $12.96M |
Short-Term Investments | |||
Other Short-Term Assets | $784.7K | $695.3K | $390.0K |
YoY Change | 112.09% | 79.07% | |
Inventory | $171.5K | $256.2K | $201.2K |
Prepaid Expenses | |||
Receivables | $399.9K | $382.3K | $297.0K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $10.72M | $7.874M | $13.85M |
YoY Change | -27.96% | -43.13% | 1107.71% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $173.1K | $187.5K | $77.15K |
YoY Change | 11.44% | 143.05% | 257.79% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $207.0K | $219.6K | $50.00K |
YoY Change | 313.96% | 322.27% | |
Total Long-Term Assets | $380.1K | $407.1K | $129.2K |
YoY Change | 83.32% | 215.21% | -74.77% |
TOTAL ASSETS | |||
Total Short-Term Assets | $10.72M | $7.874M | $13.85M |
Total Long-Term Assets | $380.1K | $407.1K | $129.2K |
Total Assets | $11.10M | $8.282M | $13.97M |
YoY Change | -26.43% | -40.74% | 742.75% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $525.6K | $426.7K | $1.280M |
YoY Change | 119.01% | -66.59% | |
Accrued Expenses | $784.8K | $1.317M | $0.00 |
YoY Change | 10.54% | -100.0% | |
Deferred Revenue | $84.12K | ||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $1.578M | $1.856M | $1.485M |
YoY Change | 41.35% | 24.95% | -50.52% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $0.00 | $40.00K |
YoY Change | -100.0% | -100.0% | |
Total Long-Term Liabilities | $0.00 | $0.00 | $40.00K |
YoY Change | -100.0% | -100.0% | -98.86% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.578M | $1.856M | $1.485M |
Total Long-Term Liabilities | $0.00 | $0.00 | $40.00K |
Total Liabilities | $1.578M | $1.856M | $1.529M |
YoY Change | 35.82% | 21.35% | -76.53% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$45.41M | -$34.97M | |
YoY Change | 21.69% | 52.88% | |
Common Stock | $57.54M | $47.43M | |
YoY Change | 4639978.95% | 42343675.89% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $6.464K | $6.464K | |
YoY Change | 0.0% | 0.0% | |
Treasury Stock Shares | $808.00 | ||
Shareholders Equity | $9.436M | $6.426M | $12.45M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $11.10M | $8.282M | $13.97M |
YoY Change | -26.43% | -40.74% | 742.75% |
Cashflow Statement
Concept | 2019 Q1 | 2018 | 2017 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.598M | -$10.32M | -$1.900M |
YoY Change | 10.77% | -14.72% | 57.02% |
Depreciation, Depletion And Amortization | $21.63K | $69.68K | $0.00 |
YoY Change | 48.14% | 510.44% | |
Cash From Operating Activities | -$3.120M | -$9.606M | -$1.430M |
YoY Change | 37.72% | 56.11% | 58.89% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $5.404K | $126.9K | -$60.00K |
YoY Change | -91.68% | 89.35% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$5.404K | -$126.9K | -$60.00K |
YoY Change | -91.68% | 89.35% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $5.600M | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 5.818M | 3.338M | 9.490M |
YoY Change | 66.83% | -81.84% | 684.3% |
NET CHANGE | |||
Cash From Operating Activities | -3.120M | -9.606M | -1.430M |
Cash From Investing Activities | -5.404K | -126.9K | -60.00K |
Cash From Financing Activities | 5.818M | 3.338M | 9.490M |
Net Change In Cash | 2.693M | -6.396M | 8.000M |
YoY Change | 132.73% | -152.59% | 2480.65% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$3.120M | -$9.606M | -$1.430M |
Capital Expenditures | $5.404K | $126.9K | -$60.00K |
Free Cash Flow | -$3.125M | -$9.733M | -$1.370M |
YoY Change | 34.12% | 56.47% | 52.22% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2018 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2018 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2018 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2019Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
17083715 | |
CY2018Q2 | dei |
Entity Public Float
EntityPublicFloat
|
32962311 | |
CY2018Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
382258 | |
CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
297039 | |
CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
256149 | |
CY2017Q4 | us-gaap |
Inventory Net
InventoryNet
|
201155 | |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
6540794 | |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
12959373 | |
CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
695276 | |
CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
388275 | |
CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
7874477 | |
CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
13845842 | |
CY2018Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
75000 | |
CY2017Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
52000 | |
CY2018Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
144582 | |
CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
187513 | |
CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
77150 | |
CY2018Q4 | us-gaap |
Assets
Assets
|
8281572 | |
CY2017Q4 | us-gaap |
Assets
Assets
|
13974992 | |
CY2018Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
1743427 | |
CY2017Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
1277236 | |
CY2018Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
3661 | |
CY2017Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
39930 | |
CY2018Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
1990 | |
CY2017Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
61288 | |
CY2018Q4 | us-gaap |
Customer Advances Current
CustomerAdvancesCurrent
|
106609 | |
CY2017Q4 | us-gaap |
Customer Advances Current
CustomerAdvancesCurrent
|
106718 | |
CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1855687 | |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1485172 | |
CY2018 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-12-31 | |
CY2018 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001369290 | |
CY2018 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2018 | dei |
Document Type
DocumentType
|
10-K | |
CY2018 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2018 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2018 | |
CY2018 | dei |
Entity Registrant Name
EntityRegistrantName
|
MYOMO INC | |
CY2018 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2018 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2018 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2018 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2018 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2018 | dei |
Trading Symbol
TradingSymbol
|
MYO | |
CY2018 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2018 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1838633 | |
CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1751731 | |
CY2018 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
10405609 | |
CY2017 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
5849969 | |
CY2017 | us-gaap |
Operating Expenses
OperatingExpenses
|
7601700 | |
CY2017Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
44042 | |
CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
1855687 | |
CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
1529214 | |
CY2018 | us-gaap |
Gross Profit
GrossProfit
|
1715825 | |
CY2017 | us-gaap |
Gross Profit
GrossProfit
|
1053586 | |
CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
47423915 | |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1245 | |
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1114 | |
CY2018Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2018Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
51720630 | |
CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12097479 | |
CY2017 | us-gaap |
Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
|
274011 | |
CY2017 | us-gaap |
Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
|
287779 | |
CY2018 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-10316739 | |
CY2017 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-12659269 | |
CY2018 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
12292402 | |
CY2017 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4317864 | |
CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-45289526 | |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-34972787 | |
CY2018Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
6464 | |
CY2017Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
6464 | |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6425885 | |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
12445778 | |
CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8281572 | |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
13974992 | |
CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
12450187 | |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
11139667 | |
CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
12449379 | |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
11138859 | |
CY2018Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2018Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
25000000 | |
CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
25000000 | |
CY2018Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2018Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2018Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
808 | |
CY2017Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
808 | |
CY2018 | us-gaap |
Revenues
Revenues
|
2444104 | |
CY2017 | us-gaap |
Revenues
Revenues
|
1558866 | |
CY2018 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
728279 | |
CY2017 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
505280 | |
CY2018 | us-gaap |
Operating Expenses
OperatingExpenses
|
12244242 | |
CY2018 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10528417 | |
CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6548114 | |
CY2017 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-135244 | |
CY2018 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
36269 | |
CY2017 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
116795 | |
CY2017 | myo |
Debt Discount On Convertible Notes
DebtDiscountOnConvertibleNotes
|
5172000 | |
CY2018 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
175409 | |
CY2017 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-358916 | |
CY2018 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
211678 | |
CY2017 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-5549365 | |
CY2018 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10316739 | |
CY2018 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.84 | |
CY2017 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-2.93 | |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-17530456 | |
CY2017 | myo |
Preferred Stock Accretion Of Redemption Discount Premium
PreferredStockAccretionOfRedemptionDiscountPremium
|
274011 | |
CY2017 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
2922885 | |
CY2017 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
12946252 | |
CY2017 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
5467389 | |
CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
|
5172000 | |
CY2018 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
814666 | |
CY2017 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
10407706 | |
CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
156725 | |
CY2017 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
26954 | |
CY2017 | myo |
Common Stock Issued For Warrants Exercised
CommonStockIssuedForWarrantsExercised
|
102660 | |
CY2017 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
30000 | |
CY2017 | myo |
Stock Issued During Period Value Repayment Of Notes
StockIssuedDuringPeriodValueRepaymentOfNotes
|
1217172 | |
CY2017 | myo |
Stock Issued During Period Value Issued For License Agreement
StockIssuedDuringPeriodValueIssuedForLicenseAgreement
|
1845 | |
CY2017 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
279508 | |
CY2018 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
-74213 | |
CY2018 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
2 | |
CY2018 | myo |
Common Stock Issued For Warrants Exercised
CommonStockIssuedForWarrantsExercised
|
3556391 | |
CY2017 | myo |
Offering Cost From Sale Of Private Placement
OfferingCostFromSaleOfPrivatePlacement
|
2500 | |
CY2018 | us-gaap |
Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
|
22819 | |
CY2018 | us-gaap |
Profit Loss
ProfitLoss
|
-10316739 | |
CY2017 | us-gaap |
Profit Loss
ProfitLoss
|
-12097479 | |
CY2018 | us-gaap |
Depreciation
Depreciation
|
69682 | |
CY2017 | us-gaap |
Depreciation
Depreciation
|
11415 | |
CY2018 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
814666 | |
CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
279508 | |
CY2018 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
16275 | |
CY2017 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
17765 | |
CY2017 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
5172000 | |
CY2018 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
32645 | |
CY2017 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
42355 | |
CY2017 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
31845 | |
CY2018 | myo |
Fair Value Of Warrants And Derivative Liabilities
FairValueOfWarrantsAndDerivativeLiabilities
|
36269 | |
CY2017 | myo |
Fair Value Of Warrants And Derivative Liabilities
FairValueOfWarrantsAndDerivativeLiabilities
|
116795 | |
CY2018 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
101494 | |
CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
182533 | |
CY2018 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
140817 | |
CY2017 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
161075 | |
CY2018 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
307001 | |
CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
235938 | |
CY2018 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
466191 | |
CY2017 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
563225 | |
CY2017 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-377503 | |
CY2018 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-103340 | |
CY2017 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
38067 | |
CY2018 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-109 | |
CY2017 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
106718 | |
CY2018 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9606310 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6153419 | |
CY2018 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
126867 | |
CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
67002 | |
CY2018 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-126867 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-67002 | |
CY2018 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
144582 | |
CY2018 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
74213 | |
CY2018 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
2 | |
CY2017 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
26954 | |
CY2018 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
3556391 | |
CY2017 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
102660 | |
CY2017 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
4368315 | |
CY2017 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
2922885 | |
CY2017 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
1770000 | |
CY2017 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1215900 | |
CY2018 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3337598 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
18382620 | |
CY2018 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-6395579 | |
CY2017 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
12162199 | |
CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
13011373 | |
CY2016Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
849174 | |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
6615794 | |
CY2017 | us-gaap |
Interest Paid Net
InterestPaidNet
|
97099 | |
CY2018 | myo |
Inventory Capitalized As Sales Demo Equipment
InventoryCapitalizedAsSalesDemoEquipment
|
53178 | |
CY2017 | myo |
Conversion Of Accrued Interest To Principal
ConversionOfAccruedInterestToPrincipal
|
21916 | |
CY2017 | myo |
Exchange Of Convertible Promissory Notes
ExchangeOfConvertiblePromissoryNotes
|
430000 | |
CY2017 | myo |
Accretion Of Convertible Preferred Stock To Redemption Value
AccretionOfConvertiblePreferredStockToRedemptionValue
|
274011 | |
CY2017 | myo |
Conversion Of Convertible Preferred Stock Into Common Stock
ConversionOfConvertiblePreferredStockIntoCommonStock
|
12946252 | |
CY2017 | myo |
Conversion Of Accrued Interest On Convertible Notes In To Common Stock
ConversionOfAccruedInterestOnConvertibleNotesInToCommonStock
|
5467389 | |
CY2017 | myo |
Issuance Of Selling Agent Warrants In Connection With Ipo
IssuanceOfSellingAgentWarrantsInConnectionWithIPO
|
156725 | |
CY2017 | myo |
Deferred Offering Costs To Additional Paid In Capital Upon Ipo Closing
DeferredOfferingCostsToAdditionalPaidInCapitalUponIPOClosing
|
438237 | |
CY2017 | us-gaap |
Stock Issued1
StockIssued1
|
1217172 | |
CY2017 | myo |
Gross Proceeds From Initial Public Offering
GrossProceedsFromInitialPublicOffering
|
4991236 | |
CY2017Q4 | myo |
Offering Costs
OfferingCosts
|
622921 | |
CY2016 | myo |
Differed Offering Costs
DifferedOfferingCosts
|
438237 | |
CY2018 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note 1 — Description of Business</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Myomo Inc. (“Myomo” or the Company”) is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro ® myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company sells the product to orthotics and prosthetics (O&P) providers, the Veterans Health Administration (VA), rehabilitation hospitals, and through distributors. Recently, the Company has begun providing devices directly to patients and billing their insurance companies directly, utilizing the clinical services of O&P providers for which they are paid a fee. The Company was incorporated in the State of Delaware on September 1, 2004 and is headquartered in Cambridge, Massachusetts.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Initial Public Offering under Regulation A and Private Placement under Regulation D</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 9, 2017, the Company completed its initial public offering (“IPO”) under Regulation A of the Securities Act of 1933, as amended, raising $4,991,235, before selling agent and other offering expenses of $1,061,157, through the sale of 665,498 shares of its common stock at a price to the public of $7.50 per share. On June 9, 2017, concurrent with the closing of the IPO, the Company also closed on a private placement under Regulation D Rule 506(b) pursuant to which it sold to accredited investors an aggregate of 557,216 units at $5.25 per unit, for aggregate proceeds of $2,925,385, before offering expenses of $2,500. Each unit consisted of one share of common stock and a three-year warrant to purchase one share of common stock exercisable for $7.50 per share. The combined aggregate gross proceeds raised were $7,916,620.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the closing of the Company’s IPO on June 9, 2017, the Company filed an amended and restated certificate of incorporation and restated bylaws, both of which were approved by the Company’s board of directors and stockholders on October 23, 2016. Pursuant to the amended and restated certificate of incorporation, the Company is authorized to issue up to 125,000,000 shares of stock, consisting of 100,000,000 shares of common stock, par value $0.0001 and 25,000,000 shares of undesignated Preferred Stock, par value of $0.0001.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Follow-on Public Offering</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 4, 2017, the Company completed a follow-on public offering (“FPO”) in which the Company sold 4,175,000 shares of its common stock and 4,175,000 warrants to purchase shares of its common stock, at a price to the public of $2.40. The warrants, of which warrants to purchase 3,560,894 shares of common stock were outstanding as of December 31, 2018, are exercisable at an exercise price of $2.95 per share of common stock, and they expire on December 4, 2022. See Note 14 – Subsequent Events. On December 6, 2017, the Company’s underwriters on the FPO exercised in full its option to purchase 626,250 shares of common stock and accompanying warrant at a combined price to the public of $2.40 per combination. After giving effect to the full exercise of the over-allotment, the Company sold an aggregate of 4,801,250 shares of common stock and accompanying warrants to purchase an aggregate of 4,801,250 shares of common stock, raising $11,523,000 before underwriting discounts and other offering expenses of $1,115,000.</p> | |
CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6646447 | |
CY2018 | us-gaap |
Advertising Expense
AdvertisingExpense
|
136300 | |
CY2017 | us-gaap |
Advertising Expense
AdvertisingExpense
|
31000 | |
CY2018 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America require management to make estimates and assumptions that affect certain reported amounts and disclosures. These estimates and assumptions are reviewed on an on-going basis and updated as appropriate. Actual results could differ from those estimates. The Company’s significant estimates include the allowance for doubtful accounts, deferred tax valuation allowances, warranty obligations and reserves for slow-moving inventory.</p> | |
CY2018 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period amounts included in the statement of cash flows for the year ended December 31, 2017 have been reclassified to conform to the current year’s presentation in accordance with ASU 2017-18. See “Recent Accounting Pronouncements.”</p> | |
CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | |
CY2018 | us-gaap |
Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
|
P3Y | |
CY2018Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
288943 | |
CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
269921 | |
CY2018 | myo |
Reimbursable Expense Cost
ReimbursableExpenseCost
|
31600 | |
CY2018 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
CY2017 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
CY2018Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
426727 | |
CY2017 | myo |
Reimbursable Expense Cost
ReimbursableExpenseCost
|
11600 | |
CY2018 | myo |
Income Tax Examination Minimum Likelihood Of Tax Benefits Being Realized Upon Ultimate Settlement
IncomeTaxExaminationMinimumLikelihoodOfTaxBenefitsBeingRealizedUponUltimateSettlement
|
0.50 | |
CY2017Q2 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
7916620 | |
CY2017Q2 | us-gaap |
Capital Units Authorized
CapitalUnitsAuthorized
|
125000000 | |
CY2017Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
CY2017Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
25000000 | |
CY2017Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2018 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
814666 | |
CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
279508 | |
CY2018 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5872025 | |
CY2018Q4 | myo |
Inventory Reserves Under Consignment
InventoryReservesUnderConsignment
|
51000 | |
CY2017Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
264890 | |
CY2018Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
1027757 | |
CY2017Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
642425 | |
CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
100000 | |
CY2018 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
23452 | |
CY2018Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
146640 | |
CY2017Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
122000 | |
CY2018Q4 | us-gaap |
Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
|
135635 | |
CY2017Q4 | us-gaap |
Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
|
97980 | |
CY2018Q4 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
48874 | |
CY2017Q4 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
23530 | |
CY2018Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
331149 | |
CY2017Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
243510 | |
CY2018Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
24000 | |
CY2017Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
23739 | |
CY2017Q4 | myo |
Inventory Reserves Under Consignment
InventoryReservesUnderConsignment
|
18616 | |
CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
287631 | |
CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
108910 | |
CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
100118 | |
CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
31760 | |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
6037456 | |
CY2017 | us-gaap |
Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
|
156725 | |
CY2017 | us-gaap |
Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
|
-116795 | |
CY2017Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
39930 | |
CY2018 | us-gaap |
Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
|
-36269 | |
CY2018Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
3661 | |
CY2017Q4 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1081135 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
246344 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
210600 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
7855 | |
CY2017 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
80085 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
369004 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
375186 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
13632 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
5642 | |
CY2018 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
1172 | |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
723744 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
141847 | |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
336718 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.5133 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
2.6568 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.9717 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.3366 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.7652 | |
CY2018 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.0700 | |
CY2018 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
3.1100 | |
CY2018 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
1.6900 | |
CY2018 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
3.8700 | |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.4200 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.6906 | |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
1.9500 | |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y1M6D | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y7M24D | |
CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y6M3D | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y8M4D | |
CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y8M26D | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
132121 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
732399 | |
CY2018Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
157260 | |
CY2017Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
99879 | |
CY2018Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
141506 | |
CY2018 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
0 | |
CY2017 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
0 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.77 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.62 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2017Q2 | myo |
Warrant Outstanding To Purchase Common Stock
WarrantOutstandingToPurchaseCommonStock
|
557216 | |
CY2017Q2 | myo |
Warrants Outstanding Common Stock Exercise Price Per Share
WarrantsOutstandingCommonStockExercisePricePerShare
|
7.50 | |
CY2017Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
8.25 | |
CY2017Q2 | myo |
Fair Value Measurements Warrants Outstanding
FairValueMeasurementsWarrantsOutstanding
|
156725 | |
CY2017Q4 | myo |
Fair Value Measurements Warrants Outstanding
FairValueMeasurementsWarrantsOutstanding
|
39930 | |
CY2017Q4 | us-gaap |
Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
|
1.40 | |
CY2016Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
8228 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
6304015 | |
CY2017 | myo |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod
|
-34800 | |
CY2017Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
6277443 | |
CY2018 | myo |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod
|
-1205556 | |
CY2018Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
5071887 | |
CY2016Q4 | myo |
Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
|
8228 | |
CY2017 | myo |
Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
|
6220515 | |
CY2017 | myo |
Class Of Warrant Or Rights Exercised
ClassOfWarrantOrRightsExercised
|
-34800 | |
CY2017Q4 | myo |
Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
|
6193943 | |
CY2018 | myo |
Class Of Warrant Or Right Previously Issued Warrants Which Became Exerciseable
ClassOfWarrantOrRightPreviouslyIssuedWarrantsWhichBecameExerciseable
|
83500 | |
CY2018 | myo |
Class Of Warrant Or Rights Exercised
ClassOfWarrantOrRightsExercised
|
-1205556 | |
CY2018Q4 | myo |
Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
|
5071887 | |
CY2016Q4 | myo |
Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
|
6.47 | |
CY2017 | myo |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.84 | |
CY2017 | myo |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice
|
2.95 | |
CY2017Q4 | myo |
Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
|
3.85 | |
CY2018 | myo |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Previously Issued Warrants Which Became Exerciseable In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPreviouslyIssuedWarrantsWhichBecameExerciseableInPeriodWeightedAverageExercisePrice
|
2.40 | |
CY2018 | myo |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice
|
2.95 | |
CY2018Q4 | myo |
Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
|
4.05 | |
CY2016Q4 | myo |
Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
|
6.47 | |
CY2017 | myo |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePriceExercisable
|
3.85 | |
CY2017 | myo |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Exercise Price Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePriceExercisable
|
2.95 | |
CY2017Q4 | myo |
Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
|
3.86 | |
CY2018 | myo |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Previously Issued Warrants Which Became Exerciseable In Period Weighted Average Exercise Price Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPreviouslyIssuedWarrantsWhichBecameExerciseableInPeriodWeightedAverageExercisePriceExercisable
|
2.40 | |
CY2018 | myo |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Exercise Price Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePriceExercisable
|
2.95 | |
CY2018Q4 | myo |
Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
|
4.05 | |
CY2018 | us-gaap |
Revenue From Related Parties
RevenueFromRelatedParties
|
306200 | |
CY2017 | us-gaap |
Revenue From Related Parties
RevenueFromRelatedParties
|
53500 | |
CY2018Q4 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
0 | |
CY2017Q4 | us-gaap |
Accounts Receivable Related Parties
AccountsReceivableRelatedParties
|
77600 | |
CY2018 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
530300 | |
CY2017 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
356400 | |
CY2018 | us-gaap |
Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
|
us-gaap:ServiceMember | |
CY2017 | us-gaap |
Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
|
us-gaap:ServiceMember | |
CY2018Q4 | us-gaap |
Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
|
54300 | |
CY2017Q4 | us-gaap |
Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
|
65800 | |
CY2018 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
352800 | |
CY2017 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
221200 | |
CY2018 | myo |
Product Warranty Period
ProductWarrantyPeriod
|
P3Y | |
CY2016 | myo |
Product Warranty Period
ProductWarrantyPeriod
|
P1Y | |
CY2017Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
50725 | |
CY2016Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
63147 | |
CY2018 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-571000 | |
CY2017 | us-gaap |
Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
|
14867 | |
CY2018 | us-gaap |
Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
|
38382 | |
CY2017 | us-gaap |
Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
|
570 | |
CY2018 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
20559 | |
CY2017 | us-gaap |
Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
|
27859 | |
CY2018Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
92000 | |
CY2018 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-2065000 | |
CY2017 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-534000 | |
CY2017 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-538000 | |
CY2018 | myo |
Federal State And Local Income Tax Expense Benefit
FederalStateAndLocalIncomeTaxExpenseBenefit
|
-2636000 | |
CY2017 | myo |
Federal State And Local Income Tax Expense Benefit
FederalStateAndLocalIncomeTaxExpenseBenefit
|
-1072000 | |
CY2017 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
2909000 | |
CY2018 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-2636000 | |
CY2017 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
1837000 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.3400 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0557 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0467 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.0000 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
-0.2303 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
|
-0.0003 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
|
0.0089 | |
CY2018 | myo |
Effective Income Tax Rate Reconciliation Nondeductible Interest
EffectiveIncomeTaxRateReconciliationNondeductibleInterest
|
0.0000 | |
CY2017 | myo |
Effective Income Tax Rate Reconciliation Nondeductible Interest
EffectiveIncomeTaxRateReconciliationNondeductibleInterest
|
-0.1767 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements Domestic
EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
|
0.0000 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Settlements Domestic
EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
|
-0.1402 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.0098 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.0003 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.2556 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.1519 | |
CY2018 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | |
CY2017 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
8378000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
5925000 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
178000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
190000 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
27000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
53000 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
440000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
219000 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
9023000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
6387000 | |
CY2018Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
9023000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
6387000 | |
CY2018Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
0 | |
CY2017Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
0 | |
CY2018Q4 | myo |
Operating Loss Carryforwards Limitations
OperatingLossCarryforwardsLimitations
|
1559000 | |
CY2018Q4 | myo |
Operating Loss Carryforwards Unutilized
OperatingLossCarryforwardsUnutilized
|
5000000 | |
CY2018Q4 | us-gaap |
Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
|
1700000 | |
CY2017 | us-gaap |
Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
|
0 | |
CY2016 | us-gaap |
Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
|
0 | |
CY2018 | us-gaap |
Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
|
0 | |
CY2017Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | |
CY2018Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 |